Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-12-02Clinical Trial Update: Wide Field OCT + AI for Positive Margin Rates in Breast Conservation Surgery. [NA]
The clinical trial evaluating wide-field OCT with AI to reduce positive margin rates in breast-conserving surgery has completed.
-
CLINICAL_TRIALS research · 2024-12-02Clinical Trial Update: Albumin-bound Paclitaxel、Dalpiciclib and AI in ER-Low (1%-10%) HER2-ABC [NA]
A clinical trial update describes a not-yet-recruiting study of albumin-bound paclitaxel and dalpiciclib with AI in HR+/HER2- advanced breas…
-
CLINICAL_TRIALS research · 2024-12-02Clinical Trial Update: Adjuvant Therapy for Intermediate Risk HER2 Positive, Lymph Node Negative Early Breast Cancer With Chemotherapy Combined Target Therapy
A recruiting clinical trial evaluating adjuvant therapy that combines chemotherapy with targeted therapy for intermediate-risk HER2-positive…
-
CLINICAL_TRIALS research · 2024-12-02Clinical Trial Update: Characterization of Innate Immune System in Patients With Luminal Advanced Breast Cancer
The document is a ClinicalTrials.gov entry for a study characterizing the innate immune system in patients with luminal advanced breast canc…
-
CLINICAL_TRIALS research · 2024-12-02Clinical Trial Update: Effect of DAPAglifozin on MYOcardial Remodeling of Breast CANCER Patients Treated with Anthracycline Based Chemotherapy [Phase 3]
Phase 3 clinical trial evaluating the effect of dapagliflozin on myocardial remodeling and cardiotoxicity in breast cancer patients treated …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-12-02Clinical Trial Update: "Serratus Anterior Plane Block" Versus "Serratus Posterior Superior Plane Intercostal Plane Block" for Patients Undergoing Breast Surgery [NA]
Clinical trial comparing serratus anterior plane block versus serratus posterior superior plane intercostal plane block for postoperative pa…
-
CLINICAL_TRIALS research · 2024-12-02Clinical Trial Update: Vocorder Device Validation in Clinical Settings - Continuous Monitoring of Individuals (Vocorder Clinical Validation-VCV)
This entry documents a clinical trial for the Vocorder device validation (Vocorder Clinical Validation-VCV) to continuously monitor individu…
-
CLINICAL_TRIALS trial_result · 2024-11-29Clinical Trial Update: Efficacy and Safety of Paclitaxel Polymeric Micelles for Injection in the Treatment of Metastatic Breast Cancer [Phase 3]
A Phase 3 clinical trial is evaluating the efficacy and safety of Paclitaxel Polymeric Micelles for Injection in patients with metastatic br…
-
CLINICAL_TRIALS research · 2024-11-29Clinical Trial Update: Phase I Study to Evaluate SIM0270 Alone or in Combination in ER+, HER2- Locally Advanced or Metastatic Breast Cancer [Phase 1]
Phase I trial update evaluating SIM0270 alone and in combination for ER-positive, HER2-negative locally advanced or metastatic breast cancer…
-
CLINICAL_TRIALS trial_result · 2024-11-29Clinical Trial Update: Breast Cancer and Breast Self-examination Education [NA]
The clinical trial evaluating education on breast self-examination for breast cancer has completed.
-
CLINICAL_TRIALS research · 2024-11-29Clinical Trial Update: Phase II Neoadjuvant Pyrotinib Combined with Neoadjuvant Chemotherapy in HER2-low-expressing and HR Positive Early or Locally Advanced Breast Cancer: a Single-arm, Non-randomized, Single-center, Open Label Trial [Phase 2]
Phase II neoadjuvant trial assessing pyrotinib in combination with chemotherapy for HER2-low-expressing, hormone receptor-positive breast ca…
-
CLINICAL_TRIALS trial_result · 2024-11-29Clinical Trial Update: Prospective Multicenter Registry of Patients With Skin Metastases From Breast Cancer Treated With Electrochemotherapy
This registry update reports the completion of a multicenter prospective registry evaluating skin metastases from breast cancer treated with…
-
CLINICAL_TRIALS trial_result · 2024-11-29Clinical Trial Update: To Evaluate the Effectiveness and Safety of Single-port Robotic-assisted Subcutaneous Gland Resection Combined With Immediate Breast Reconstruction in Breast Cancer [NA]
This clinical trial aims to evaluate the effectiveness and safety of a single-port robotic-assisted subcutaneous gland resection with immedi…
-
CLINICAL_TRIALS other · 2024-11-29Clinical Trial Update: The Postoperative Radiotherapy in N1 Breast Cancer Patients [Phase 3]
Phase 3 clinical trial update noting a trial evaluating postoperative radiotherapy in N1 breast cancer patients, currently recruiting.
-
CLINICAL_TRIALS research · 2024-11-27Clinical Trial Update: Role of MRI in Breast Cancer Subtypes
This registry entry describes a clinical trial investigating the role of MRI in breast cancer subtypes, which is currently not yet recruitin…
-
CLINICAL_TRIALS research · 2024-11-27Clinical Trial Update: Short-course Trastuzumab, Pertuzumab with Taxanes in the Adjuvant Treatment of Early HER2-positive Breast Cancer [Phase 2]
Phase 2 clinical trial update describing a short-course combination of trastuzumab and pertuzumab with taxanes for early HER2-positive breas…
-
CLINICAL_TRIALS research · 2024-11-27Clinical Trial Update: IORT Following Breast Conserving Surgery for Early Stage Breast Cancer Registry
This entry describes an ongoing registry study evaluating intraoperative radiotherapy (IORT) after breast-conserving surgery for early-stage…
-
CLINICAL_TRIALS trial_result · 2024-11-26Clinical Trial Update: Pharmacokinetics and Pharmacogenomics of Ribociclib in Race-based Cohorts [Phase 4]
A Phase 4 pharmacokinetic and pharmacogenomic study of ribociclib in race-based cohorts for breast cancer was terminated; results were poste…
-
CLINICAL_TRIALS withdrawal · 2024-11-26Clinical Trial Update: Feasibility and Effectiveness of a Sleep Hygiene Education Program for Sleep Issues in Breast Cancer Survivors [NA]
A clinical trial evaluating a sleep hygiene education program for sleep issues in breast cancer survivors has been withdrawn. The study, spo…
-
CLINICAL_TRIALS withdrawal · 2024-11-26Clinical Trial Update: Effectiveness of Aquatic Exercise on Fatigue, Neuropathy and Quality of Life Among Cancer Patients [NA]
A clinical trial evaluating aquatic exercise for fatigue, neuropathy, and quality of life in colon and breast cancer patients has been withd…
-
CLINICAL_TRIALS research · 2024-11-26Clinical Trial Update: A Real-world Study of Effectiveness and Safety in HR+/HER2- Breast Cancer Patients Treated With Ribociclib or Alpelisib
This clinical trial update reports a real-world study evaluating the effectiveness and safety of ribociclib or alpelisib in HR+/HER2- breast…
-
CLINICAL_TRIALS withdrawal · 2024-11-26Clinical Trial Update: Feasibility and Effectiveness of an Internet-based Intervention to Manage Fatigue in Breast Cancer Survivors [NA]
The clinical trial NCT04160182 examining an internet-based intervention to manage fatigue in breast cancer survivors has been withdrawn. Spo…
-
CLINICAL_TRIALS research · 2024-11-25Clinical Trial Update: Patient-Reported Outcome and Safety Between Preoperative and Postmastectomy Radiotherapy in DIEP Flap Reconstruction [NA]
This clinical trial, sponsored by Fudan University, compares patient-reported outcomes and safety of preoperative versus postmastectomy radi…
-
CLINICAL_TRIALS withdrawal · 2024-11-25Clinical Trial Update: Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs
A Travera Inc clinical trial (NCT04985357) evaluating mass response as a biomarker for tumor sensitivity to drugs has been withdrawn; no res…
-
CLINICAL_TRIALS research · 2024-11-25Clinical Trial Update: A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08) [Phase 1, Phase 2]
GI Innovation's GI-102 is being studied in a phase 1/2 trial as a single agent and in combination with pembrolizumab or trastuzumab deruxtec…